| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/16/2002 | WO2001079518A3 Codon optimisation for expression in retrovirus packaging cells |
| 05/16/2002 | WO2001079492A3 Lipid binding protein 3 |
| 05/16/2002 | WO2001077329A3 Human twik molecules and uses thereof |
| 05/16/2002 | WO2001077306A3 Plant raffinose saccharide biosynthetic enzymes |
| 05/16/2002 | WO2001077171A3 Soluble zalpha11 cytokine receptors |
| 05/16/2002 | WO2001076638A3 Compositions for drug delivery |
| 05/16/2002 | WO2001075109A3 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 05/16/2002 | WO2001074857A3 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 05/16/2002 | WO2001074852A3 Protein having activity as an angiogenesis modulator |
| 05/16/2002 | WO2001073083B1 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 05/16/2002 | WO2001073049A3 33877 and 47179, human glycosyl transferase family members and uses thereof |
| 05/16/2002 | WO2001072978A3 Aryl propenal double bond reductase |
| 05/16/2002 | WO2001072967B1 Promoter sequence of 3-phosphoglycerate kinase gene 2 of rhizopus oryzae and its use |
| 05/16/2002 | WO2001072842A3 Human 7-transmembrane proteins and polynucleotides encoding the same |
| 05/16/2002 | WO2001070953A3 Identification of modulators of the inteferon gamma signaling pathway and their use in restenosis treatment |
| 05/16/2002 | WO2001068879A3 Human 1-aminocyclopropane-carboxylate synthase |
| 05/16/2002 | WO2001068806A3 26934, a novel cytidine deaminase-like molecule and uses thereof |
| 05/16/2002 | WO2001068699A3 Regulation of human neuropeptide y-like g protein-coupled receptor |
| 05/16/2002 | WO2001068144A3 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001068143A3 Immunomodulatory formulations and methods for use thereof |
| 05/16/2002 | WO2001066709A3 Sphingomyelinase enzymes and uses relating thereto |
| 05/16/2002 | WO2001066598A3 Chemoattractant receptor characterization and cell selection materials and methods and chemokine receptor ccr11 materials and methods |
| 05/16/2002 | WO2001064902A8 46867, a transferase family member and uses therefor |
| 05/16/2002 | WO2001062946A8 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds |
| 05/16/2002 | WO2001055429A3 Method for the manufacture of recombinant trypsin |
| 05/16/2002 | WO2001055317A8 Nucleic acids, proteins, and antibodies |
| 05/16/2002 | WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 05/16/2002 | WO2001047959A3 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 05/16/2002 | WO2001041739A3 Liposomes |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001034823A9 Method for enhancing resistance in plants |
| 05/16/2002 | WO2001034765A9 Methods and apparatus for the electronic, homogeneous assembly and fabrication of devices |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001032685A8 Gene expression directed by a super-psa promoter |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | WO2001032002A9 Myb transcription factors and uses thereof |
| 05/16/2002 | WO2001029255A3 Diagnostic test for cephalic pain |
| 05/16/2002 | WO2001027331A3 Detection of nucleic acid heteroduplex molecules by anion-exchange chromatography |
| 05/16/2002 | WO2001027294A9 Virus coat protein/receptor chimeras and methods of use |
| 05/16/2002 | WO2001025480A3 Dna sequencing method |
| 05/16/2002 | WO2001025408A9 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof |
| 05/16/2002 | US20020059663 Nucleotide sequences for use in generation of transgenic plant; for use in screening fungicides and insecticides |
| 05/16/2002 | US20020059662 Transgenic eukaryotic cell for use in generation drought, stress, freeze and heat resistant plant |
| 05/16/2002 | US20020059661 Nucleotide sequences coding enzymatic polypeptide for use in generating plants with reduced saturated fatty acid concentration; herbicide resistance; freeze resistance |
| 05/16/2002 | US20020059660 Expression vector for use in the generation of disease resistant plants |
| 05/16/2002 | US20020059659 DNA shuffling to produce herbicide selective crops |
| 05/16/2002 | US20020059658 Methods of improving the effectiveness of transgenic plants |
| 05/16/2002 | US20020059657 Expression vector for use in the transformation and generation of transgenic plants |
| 05/16/2002 | US20020059656 Generating genetically engineered polypeptides; obtain library of nucleotide sequences, extend nucleotide sequences, denature, incubate with primers, amplify, insert into vector, express polypeptides |
| 05/16/2002 | US20020059653 Modulating protein complex formation in cells; obtain sample tissue, incubate with acetylcholine esterase, expose to modulator, monitor sample for complex formation |
| 05/16/2002 | US20020059652 Detecting modulators of liver cell propagation, cell differentiation and lymphocyte activity; obtain modulator, incubate with indicator, mix with culture monitor culture for adjustment in activity |
| 05/16/2002 | US20020059032 Rational selection of putative peptides from identified nucleotide or peptide sequences |
| 05/16/2002 | US20020058887 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 05/16/2002 | US20020058800 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/16/2002 | US20020058797 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein |
| 05/16/2002 | US20020058795 Preferential particles for use in the transfer of macromolecules into cells; for use in gene therapy |
| 05/16/2002 | US20020058792 Method for solubilization and naturation of somatotropins |
| 05/16/2002 | US20020058791 Hybrid cytokine of IL-7 and beta-chain of hepatocyte growth factor |
| 05/16/2002 | US20020058789 Polypeptide for use as tool in the diagnosis of microorganism infections |
| 05/16/2002 | US20020058787 Mhc binding peptide oligomers and methods of use |
| 05/16/2002 | US20020058639 Complexes carry primary moieties, chiefly therapeutic, to target cells; feature cell surface receptor ligands to provide specificity; ligands are preferably bound to primary moieties through polyfunctional manifold compounds. |
| 05/16/2002 | US20020058638 Decreasing blood glucose levels, inhibiting PEPCK expression, decreasing blood insulin levels, decreasing insulin resistance, increasing insulin sensitivity, decreasing blood triglyceride levels or decreasing blood cholesterol levels |
| 05/16/2002 | US20020058637 Methods of inhibiting tau-protein kinase I activity, inhibiting neuronal cell death and treating alzheimer's disease and tau-protein kinase I |
| 05/16/2002 | US20020058636 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 05/16/2002 | US20020058619 Ligand for vascular endothelial growth factor receptor |
| 05/16/2002 | US20020058614 Especially administered by direct injection into the afflicted cartilagenous region or joint. |
| 05/16/2002 | US20020058613 Modulating the expression or bioactivity of a bcl family member in a neural cell such that axonal growth occurs. |
| 05/16/2002 | US20020058612 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
| 05/16/2002 | US20020058610 DNA (RNA) encoding such polypeptide and a procedure for producing such polypeptide by recombinant techniques; inhibiting such polypeptide for preventing and/or treating neoplasia; diagnostic assays |
| 05/16/2002 | US20020058341 Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell |
| 05/16/2002 | US20020058340 Down-regulation of single genes and simultaneous down-regulation of multiple genes by nuclear localization of RNA transcripts |
| 05/16/2002 | US20020058334 Cells, genetically modified with optical marker |
| 05/16/2002 | US20020058329 Multiple-site reaction device and method |
| 05/16/2002 | US20020058328 Polypeptide for use in treatment of infections, pain, cancers, diabetes, asthma, eating, psychogical, nevrous system and cardiovascular disoreder, stroke, ulcers, allergies, migraine, vomiting and dyskinesias |
| 05/16/2002 | US20020058326 Microorganism for use in the diagnsis of cancer and treatment of lactase defect |
| 05/16/2002 | US20020058325 Recombinant AAV packaging systems |
| 05/16/2002 | US20020058324 Protein recovery |
| 05/16/2002 | US20020058322 DNA molecules encoding fibrinolytically active polypeptide |
| 05/16/2002 | US20020058321 Method of determining the activity of 1-deoxy-D-xylulose-5-phosphate reductoisomerase and 1-deoxy-D-xylulose-5-phosphate synthase |
| 05/16/2002 | US20020058317 Process for the fusion of dendritic cells with abnormal tissue cells, in particular tumor cells and media for such a process |
| 05/16/2002 | US20020058315 Genetically engineered microorgansim for the generation of preferential amino acid for use in medicine and food |
| 05/16/2002 | US20020058314 DNA coding for protein which confers on bacterium escherichia coli resistance to L-homoserine, and method for producing L-amino acids |
| 05/16/2002 | US20020058313 Use of recombinant enzymes for preparing GDP-L-fucose and fucosylated glycans |
| 05/16/2002 | US20020058312 Plasmid for use in the the treatment and prevention of viral disease |
| 05/16/2002 | US20020058310 Lectin ss3939 DNA and polypeptides |
| 05/16/2002 | US20020058309 Nucleotide sequences for use in the treatment of nervous system disorders and neuronal damage |
| 05/16/2002 | US20020058305 Enzymatic polypeptide for use in diagnosis of skin disorders |
| 05/16/2002 | US20020058304 Methods for producing a polypeptide using a crippled translational initiator sequence |
| 05/16/2002 | US20020058297 Microorganism for use as model in screening microbiocides and bactericides |
| 05/16/2002 | US20020058293 Nucleotide sequences coding microorganismal protein; for use in the prevention of preferential microorganismal infection |
| 05/16/2002 | US20020058290 Stable genetically engineered muscle cell; for use in the generation of modulators for treatment of cancer, metabolic defects, cachexia and aging defects |
| 05/16/2002 | US20020058288 Compound for use in the detection and prevention of parasitic infection of humans |
| 05/16/2002 | US20020058287 Novel small nuclear RNA vectors and uses therefor |
| 05/16/2002 | US20020058275 Adjustment of defective fitting nucleotide sequences; obtain nucleotide sequence samples, incubate dimer binding protein, monitor sample for bound complexes |
| 05/16/2002 | US20020058274 Rapidly degrading GFP-fusion proteins and methods of use |
| 05/16/2002 | US20020058272 Luminescent marker; for use in the detection of preferential nucleotide sequences |
| 05/16/2002 | US20020058270 Methods and compositions for transcription-based nucleic acid amplification |
| 05/16/2002 | US20020058269 Detecting preferential bacteriophage in a library; obtain target particles, incubate with unclarified culture, propagate, detect viral particle which express preferential fusion protein |
| 05/16/2002 | US20020058268 Generating preferential nucleotide sequence libraries; obtain nucleotide sequence, denature, incubate with primers and recombinases, amplify sequences, recover nucleotide sequences |
| 05/16/2002 | US20020058267 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |